~~<i id='C39927E001'><strike id='C39927E001'><tt id='C39927E001'><pre id='C39927E001'></pre></tt></strike></i>~~

Home» Wikipedia» Wikipedia

Wikipedia

author：focus 2025-10-02 03:20:27 Page View：955

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： GOP presidential candidates start declaring their loyalty
Next article： After affirmative action ruling, medical educators look to 'holistic review'

explore

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

TB outbreak tied to bone grafts underscores testing shortcomings

WikimediaCommons/NIAIDOnepersonhasdiedandatleastfourhavebeensickenedbytuberculosisininfectedbonemate

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

CDC overhauls leadership of center that led response to Covid

DemetreDaskalakis,whohasspentthepastyearinWashingtonasdeputydirectoroftheWhiteHouse’smpoxresponse,wa